Company profile

Ticker
PTE
Exchange
CEO
Denver M. Lough
Employees
Incorporated in
Location
Fiscal year end
Former names
Cdbeat Com Inc, Connectiv Corp, Connectivcorp, Majesco Entertainment Co, Majesco Holdings Inc, SMD Group Inc, Spinrocket Com Inc
SEC CIK
IRS number
61529524

PTE stock data

(
)

Calendar

8 Aug 19
22 Sep 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Jun 19 Mar 19 Oct 18 Jul 18
Revenue 1.33M 1.47M 1.13M 416K
Net income -22.79M -25.57M -22.49M -17.25M
Diluted EPS -0.92 -1.18 -0.96 -0.86
Net profit margin -1719% -1746% -1988% -4145%
Operating income -23.08M -25.81M -23M -17.39M
Net change in cash 10.94M -36.01M -13.87M
Cash on hand 45.89M 34.95M 70.96M 84.83M
Cost of revenue 596K 776K 771K 229K

Financial data from PolarityTE earnings reports

Financial report summary

?
Competition
Arc
Management Discussion
  • Net Revenues. For the three-month period ended June 30, 2019, total net revenues were $1.3 million. Products revenues from the sale of SkinTE were $0.5 million for the three months ended June 30, 2019 compared to $0.2 million for the three months ended June 30, 2018. Net revenues from services for the three months ended June 30, 2019 were $0.8 million from the contract research segment operations driven primarily by the IBEX preclinical research business. The IBEX business was acquired in May 2018 and contributed $0.1 million to revenue in the three-months ending June 30, 2018.
  • Cost of Sales. For the three-month period ended June 30, 2019, total cost of sales was approximately $0.6 million and approximately 45% of total net revenues. Products cost of sales were $0.3 million or 68% of products revenues primarily due to fixed overhead costs. Services cost of sales were $0.3 million or 31% of services revenues. Product cost of sales for the three-month period ended June 30, 2018 were $0.1 million or 66% of products revenues. Services cost of sales for the three-month period ended June 30, 2018 were $0.04 million or 31% of services revenues.
  • Research and Development Expenses. Research and development expenses increased $1.8 million, or 63%, in the three-month period ended June 30, 2019, compared to the three-month period ended June 30, 2018. The increase is primarily driven by an increase in research and clinical support personnel with associated wage and benefits cost year over year.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: accrual, budget, department, discipline, duration, ESPP, executory, Hague, high, immaterial, lesser, low, Mann, match, matching, Nonrefundable, notice, opposition, outsourcing, overstatement, parallel, Paul, platform, prioritizing, quantitative, reply, reserved, run, salary, site, trial, wage
Removed: accounted, bring, Cantor, cliff, combination, criteria, Fitzgerald, intrinsic, modification, month, representing, short, underwriter, unvested